PHQ-9 (Patient Health Questionnaire-9)
iatroX editorial team · Updated · Record checked · editorial policy
The PHQ-9 is a 9-item self-report questionnaire that scores each of the DSM criteria for major depressive disorder on a 0–3 severity scale. It is the most widely validated depression screening and severity monitoring tool in primary care worldwide. Total scores range from 0 to 27.
questionnaire
evidence
derivation
Developed by Kroenke, Spitzer, and Williams (2001) as part of the Patient Health Questionnaire suite. Derived from the PRIME-MD diagnostic instrument. Validated in 6,000 patients across 8 primary care and 7 obstetrics-gynaecology clinics. Each item maps directly to one of the nine DSM-IV (now DSM-5) diagnostic criteria for major depressive disorder.
validation
Internal consistency: Cronbach's alpha 0.86–0.89. Criterion validity: at a cut-off of ≥10, sensitivity 88% and specificity 88% for major depressive disorder against structured clinical interview. A massive study by Bianchi et al. (2022, n > 58,000) confirmed the PHQ-9 is essentially unidimensional and demonstrates measurement invariance across demographic groups and nationalities. Test-retest reliability is excellent (r = 0.84 between in-person and telephone administration).
guideline endorsements
NICE CG90/CG91 (Depression in Adults): endorses PHQ-9 for severity assessment and treatment monitoring. USPSTF recommends screening for depression in all adults, with the PHQ-9 as a commonly used instrument. Endorsed by the American Psychiatric Association, WHO mhGAP, and the Canadian Network for Mood and Anxiety Treatments (CANMAT).
regional interpretation
references
- Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.PMID: 11556941
- Gilbody S, Richards D, Brealey S, Hewitt C. Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis. J Gen Intern Med. 2007;22(11):1596-1602.PMID: 17874169
- Bianchi R, Verkuilen J, Schonfeld IS, et al. Is the PHQ-9 fit for purpose as a unidimensional measure of depression? A study involving 58,272 participants from 29 samples. J Affect Disord. 2022;310:207-214.PMID: 35589014
- Levis B, Benedetti A, Thombs BD. Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ. 2019;365:l1476.PMID: 30967483
- NICE Clinical Guideline CG90. Depression in adults: recognition and management. National Institute for Health and Care Excellence; 2009 (updated 2022).link ↗